Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29456717 | 1.00 | ALDH1A1 (0.40) | ALDH1A1HIF1AHSD17B10CYP1B1KDM4E | |
| SCHEMBL26644609 | 0.85 | ALDH1A1 (0.32) | ALDH1A1HIF1AHSD17B10CYP1B1KDM4E | |
| SCHEMBL474149 | 0.82 | ALDH1A1 (0.46) | ALDH1A1HIF1AHSD17B10CYP1B1KDM4E | |
| SCHEMBL5083299 | 0.81 | ALDH1A1 (0.45) | ALDH1A1HIF1AHSD17B10CYP1B1KDM4E | |
| SCHEMBL30678718 | 0.79 | ALDH1A1 (0.46) | ALDH1A1HSD17B10KDM4EMAPTCYP3A4 | |
| SCHEMBL31389329 | 0.78 | ALDH1A1 (0.47) | ALDH1A1HIF1AHSD17B10CYP1B1KDM4E | |
| SCHEMBL31619715 | 0.77 | ALDH1A1 (0.45) | ALDH1A1HIF1AHSD17B10CYP1B1KDM4E | |
| SCHEMBL4651081 | 0.77 | ALDH1A1 (0.45) | ALDH1A1HIF1AHSD17B10CYP1B1KDM4E | |
| SCHEMBL30132322 | 0.76 | CCR1 (0.60) | ALDH1A1HIF1AHSD17B10CYP1B1KDM4E | |
| SCHEMBL5821259 | 0.76 | CCR1 (0.60) | ALDH1A1HIF1AHSD17B10CYP1B1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 622 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8076072-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2011-12-13 | — | — | US | claimed |
| US-8026057-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2011-09-27 | — | — | US | claimed |
| US-7468243-B2 | Nucleotide sequence labelling compoumd four use as tool in genetic engineering | AFFYMETRIX, INC. (US) | 2008-12-23 | — | — | US | claimed |
| US-7291463-B2 | Incubating/condensating pseudoisocytidine molecule with (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to provide a pseudouridine molecule; oncology diagnosis | AFFYMETRIX, INC. (US) | 2007-11-06 | — | — | US | claimed |
| US-7282327-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2007-10-16 | — | — | US | claimed |
| US-20260035749-A1 | METHODS AND COMPOSITIONS FOR PREDICTING AND/OR MONITORING CARDIOVASCULAR DISEASE AND TREATMENTS THEREFOR | CARDIO DIAGNOSTICS INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12297221-B2 | Functionalization and purification of molecules by reversible group exchange | ILLUMINA, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-20240384262-A1 | LINKING SEQUENCE READS USING PAIRED CODE TAGS | ILLUMINA, INC. | 2024-11-21 | — | — | US | disclosed |
| US-20240360513-A1 | COMPOSITIONS AND METHODS FOR DETECTING PREDISPOSITION TO CARDIOVASCULAR DISEASE | UNIV IOWA RES FOUND (US) | 2024-10-31 | — | — | US | disclosed |
| US-20240327916-A1 | METHODS AND COMPOSITIONS FOR PREDICTING AND/OR MONITORING CARDIOVASCULAR DISEASE AND INTERVENTIONS THEREFOR | Cardio Diagnostics, Inc. | 2024-10-03 | — | — | US | disclosed |
| US-12043869-B2 | Compositions and methods for detecting predisposition to cardiovascular disease | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2024-07-23 | — | — | US | disclosed |
| US-11993772-B2 | Linking sequence reads using paired code tags | ILLUMINA, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-4272506-A | BINDING A LABELED MEMBER OF A SPECIFIC BINDING PAIR TO A MERCAPTO-ACTIVATED SUPPORT THROUGH CLEAVABLE DISULFIDE LINKAGES; IMMUNOASSAY; ACCURACY | SYVA COMPANY (US) | 1981-06-09 | — | — | US | disclosed |
| US-4256834-A | REPRESSING THE SIGNALS PRODUCED BY UNBOUND LABELS; SENSITIVITY | SYVA COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
| EP-0022768-A1 | MACROMOLECULAR ENVIRONMENT CONTROL IN SPECIFIC RECEPTOR ASSAYS. | SYVA CO (US) | 1981-01-28 | — | — | EP | disclosed |
| EP-0017908-A1 | A method for determining the presence in a sample of an analyte and a kit for use in this method | SYVA COMPANY (US) | 1980-10-29 | — | — | EP | disclosed |
| EP-0015695-A1 | Support-ligand analog-fluorescer conjugate and serum assay method involving such conjugate | SYVA COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
| EP-0022768-A4 | MACROMOLECULAR ENVIRONMENT CONTROL IN SPECIFIC RECEPTOR ASSAYS. | SYVA CO (US) | 1980-08-18 | — | — | EP | disclosed |
| US-4193983-A | Labeled liposome particle compositions and immunoassays therewith | SYVA COMPANY (US) | 1980-03-18 | — | — | US | disclosed |
| WO-1979000882-A1 | MACROMOLECULAR ENVIRONMENT CONTROL IN SPECIFIC RECEPTOR ASSAYS | SYVA CO (US) | 1979-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035749-A1 | METHODS AND COMPOSITIONS FOR PREDICTING AND/OR MONITORING CARDIOVASCULAR DISEASE AND TREATMENTS THEREFOR | DNMT3A, MECP2, DNMT3L | ALDH1A1 1098/4885HIF1A 1826/4885HSD17B10 1383/4885 |
| US-12297221-B2 | Functionalization and purification of molecules by reversible group exchange | PHAX, ALKBH1, JMJD6 | ALDH1A1 4037/4885HIF1A 4465/4885HSD17B10 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.